Novel methods of treating hearing loss
US-2024390323-A1 · Nov 28, 2024 · US
Water-soluble meloxicam granules
US8992980B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-8992980-B2 |
| Application number | US-69456903-A |
| Country | US |
| Kind code | B2 |
| Filing date | Oct 27, 2003 |
| Priority date | Oct 25, 2002 |
| Publication date | Mar 31, 2015 |
| Grant date | Mar 31, 2015 |
How to read this patent
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
- Title
What the patent document calls the invention.
- Abstract
A short plain-language summary of the technical disclosure.
- Assignees and inventors
Who owns or filed the patent and who is credited as inventor.
- Key dates
Filing, priority, publication, and grant dates set the timeline.
- First independent claim
The legal scope of protection — read this for what is actually claimed.
- CPC / IPC classifications
Technology tags used to group this patent with similar filings.
- Citations and related patents
Prior art links and similar publications in this corpus.
Abstract
Official abstract text for this publication.
Water soluble meloxicam granules comprising: (a) meloxicam; (b) a salt forming agent which forms the meglumine, sodium, potassium, or ammonium salt of meloxicam; (c) a binder; (d) a sugar or sweetener; and (e) a carrier, and optionally a flavoring agent and optionally other excipients, processes for preparing them and their use for treating respiratory or inflammatory complaints in mammals.
First claim
Opening claim text (preview).
We claim: 1. Water soluble granules consisting of: (a) meloxicam; (b) a salt forming agent which forms the meglumine, sodium, potassium, or ammonium salt of meloxicam; (c) a binder; (d) a sugar or sweetener; and (e) a carrier, and optionally a flavoring agent; wherein 5 g of said granules dissolve in 100 mL of demineralized water in about 1 minute to form a clear solution, and the water soluble granules do not include cyclodextrin. 2. The water so…
Assignees
Inventors
Classifications
- A61K31/5415Primary
Human Necessities · mapped topic
- A61K9/5078Primary
Human Necessities · mapped topic
Human Necessities · mapped topic
Human Necessities · mapped topic
Human Necessities · mapped topic
Patent family
Related publications grouped by family.
External sources
Next steps
Free tools are coming soon. Tell us what you want to track and we'll notify you.
Frequently asked questions
Answers are generated from the same data shown on this page.
- What does patent US8992980B2 cover?
- Water soluble meloxicam granules comprising: (a) meloxicam; (b) a salt forming agent which forms the meglumine, sodium, potassium, or ammonium salt of meloxicam; (c) a binder; (d) a sugar or sweetener; and (e) a carrier, and optionally a flavoring agent and optionally other excipients, processes for preparing them and their use for treating respiratory or inflammatory complaints …
- Who is the assignee on this patent?
- Henke Stefan, Folger Martin Andreas, Schmalz Jens, and 4 more
- What technology area does this patent fall under?
- Primary CPC classification A61K31/5415. Mapped technology areas include Human Necessities.
- When was this patent published?
- Publication date Tue Mar 31 2015 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
- What related patents are in patentsdb?
- We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).